Personalizing Approaches to Management of HPV+ Oropharyngeal Cancer. Cancer J 2025 May-Jun 01;31(3)
Date
06/03/2025Pubmed ID
40459976DOI
10.1097/PPO.0000000000000768Scopus ID
2-s2.0-105007158439 (requires institutional sign-in at Scopus site)Abstract
HPV+ oropharyngeal cancer represents a unique disease entity in the realm of head and neck cancer with distinct incidence and prevalence, pathogenesis, and treatment outcome. Management of this disease needs to be personalized in consideration of a combination of factors of both patient and disease characteristics. Overall outcomes in this patient population are excellent. Therefore, late side effects of treatment are gaining increasing importance and attention. Here we present a brief overview of personalized approaches for this patient population, illustrated by a discussion of several cases.
Author List
Zhu F, Awan MAuthor
Musaddiq J. Awan MD Associate Professor in the Radiation Oncology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Disease ManagementHumans
Male
Oropharyngeal Neoplasms
Papillomaviridae
Papillomavirus Infections
Precision Medicine









